Yanqing Wang

Title: Yanqing Wang - Innovator in Sustained-Release Drug Delivery

Introduction

Yanqing Wang is a notable inventor based in Zhuhai, China. He has made significant contributions to the field of pharmaceutical technology, particularly in drug delivery systems. His innovative work focuses on the development of sustained-release formulations that enhance the efficacy of medications.

Latest Patents

Yanqing Wang holds a patent for an "Aripiprazole sustained-release microsphere and preparation method therefor." This invention provides a novel microsphere formulation that comprises aripiprazole and polylactide-glycolide. The microsphere features a spherical reticular skeleton structure with reticular micropores distributed across its surface, allowing for the effective encapsulation of aripiprazole. The average particle diameter of the microsphere is less than 20 μm, making it suitable for administration through a 5 gauge needle. The content of aripiprazole in the microsphere ranges from 65% to 80% of its total weight, ensuring a controlled release of the drug.

Career Highlights

Yanqing Wang is associated with Zhuhai Livzon Microsphere Technology Co. Ltd., where he applies his expertise in drug formulation and delivery systems. His work at the company has been instrumental in advancing the development of innovative pharmaceutical products.

Collaborations

Yanqing Wang collaborates with talented professionals in his field, including Bin Chen and Xia Yin, who contribute to the research and development efforts at Zhuhai Livzon Microsphere Technology Co. Ltd.

Conclusion

Yanqing Wang's contributions to the field of sustained-release drug delivery highlight his innovative spirit and dedication to improving pharmaceutical technologies. His patent for aripiprazole microspheres exemplifies the potential for advancements in medication delivery systems.